Although NT-proBNP levels were higher and DLCO was lower in patients with CTD-PAH than in patients with iPAH, these differences did not negatively influence the survival outcome of patients with CTD-PAH. The gene discussed is NPPB; the disease is idiopathic pulmonary arterial hypertension.